Literature DB >> 30567626

Gastrointestinal effects of extra-virgin olive oil associated with lower postprandial glycemia in type 1 diabetes.

Lutgarda Bozzetto1, Antonio Alderisio1, Gennaro Clemente2, Marisa Giorgini1, Francesca Barone1, Ettore Griffo1, Giuseppina Costabile1, Claudia Vetrani1, Paola Cipriano1, Angela Giacco1, Gabriele Riccardi1, Angela Albarosa Rivellese1, Giovanni Annuzzi3.   

Abstract

OBJECTIVE: To explore the possible mechanisms behind the lower glycemic response observed when extra-virgin olive oil (EVOO) is added to a high-glycemic index meal in patients with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: According to a randomized cross-over design, eleven T1D patients (6 women, 5 men) on insulin pump consumed in the metabolic ward, one week apart, three high-glycemic index meals differing only for amount and quality of fat: high-monounsaturated fat (EVOO), high-saturated fat (Butter), and low-fat (LF). Before and after the meals, blood glucose (continuous glucose monitoring), gastric emptying rate (ultrasound technique), and plasma concentrations of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide GIP (ELISA), glucagon (RIA), and lipids (colorimetric assays) were evaluated.
RESULTS: Blood glucose iAUC (mmol/lx360 min) was lower after the EVOO (690 ± 431) than after the Butter (1320 ± 600) and LF meals (1007 ± 990) (M ± SD, p = 0.041 by repeated measures ANOVA). Gastric antrum volume was significantly larger in the early (60-90 min) postprandial phase (106 ± 21 vs. 90 ± 16 ml, p = 0.048) and significantly smaller in the late phase (330-360 min) (46 ± 10 vs. 57 ± 22 ml, p = 0.045) after the EVOO than after Butter meal. EVOO significantly increased postprandial GLP-1 iAUC (261 ± 311) compared to Butter (189 ± 349) (pmol/Lx180 min, p = 0.009). Postprandial GIP and glucagon responses were not significantly different between EVOO and Butter. Postprandial triglyceride iAUC was significantly higher after EVOO (100 ± 53) than after Butter (65 ± 60) (mmol/l × 360 min, p = 0.048).
CONCLUSIONS: Changes in gastric emptying and GLP-1 secretion and reduced glucose absorption through glucose-lipid competition may contribute to lower glycemia after a high-glycemic index meal with EVOO in T1D patients. CLINICAL TRIALS NUMBER: NCT02330939.
Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Dietary fat; Extra-virgin olive oil; Gastric emptying; Incretins; Postprandial glycemia; Type 1 diabetes

Year:  2018        PMID: 30567626     DOI: 10.1016/j.clnu.2018.11.015

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

1.  Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system.

Authors:  Claudia Vetrani; Ilaria Calabrese; Luisa Cavagnuolo; Daniela Pacella; Elsa Napolano; Silvia Di Rienzo; Gabriele Riccardi; Angela A Rivellese; Giovanni Annuzzi; Lutgarda Bozzetto
Journal:  Diabetologia       Date:  2021-10-23       Impact factor: 10.122

2.  Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial.

Authors:  Alia García; Vanessa Moscardó; Agustín Ramos-Prol; Julián Díaz; Miguel Boronat; Jorge Bondia; Paolo Rossetti
Journal:  BMJ Open Diabetes Res Care       Date:  2021-10

3.  Lifestyle and Dietary Habits Affect Plasma Levels of Specific Cytokines in Healthy Subjects.

Authors:  Vittoria D'Esposito; Michele Francesco Di Tolla; Manuela Lecce; Francesco Cavalli; Michele Libutti; Saverio Misso; Serena Cabaro; Maria Rosaria Ambrosio; Alessia Parascandolo; Bianca Covelli; Giuseppe Perruolo; Mario Sansone; Pietro Formisano
Journal:  Front Nutr       Date:  2022-06-24

Review 4.  Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties.

Authors:  Monica Bucciantini; Manuela Leri; Pamela Nardiello; Fiorella Casamenti; Massimo Stefani
Journal:  Antioxidants (Basel)       Date:  2021-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.